PMGC Holdings Inc.

ELAB
$1.33 (+ $0.12 + 9.92%)
Last updated: 2026-07-06 20:53 UTC
ELAB Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS73017P5089
CUSIP73017P508
Market Price1.33
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.0
EPS399.22
Market Cap$1.2M
Book Value11.41
Price to Book0.14
Beta0.3
52w High99.96
52w Low1.58
Next Earnings DateN/A

PMGC Holdings Inc. trades under ticker ELAB on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US73017P5089, CUSIP 73017P508.

About the Company
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Price History